{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T22:34:46Z","timestamp":1774305286910,"version":"3.50.1"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,9,27]],"date-time":"2018-09-27T00:00:00Z","timestamp":1538006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,9,27]],"date-time":"2018-09-27T00:00:00Z","timestamp":1538006400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100006545","name":"U.S. Department of Health & Human Services | NIH | National Institute on Minority Health and Health Disparities","doi-asserted-by":"publisher","award":["5G12MD007592"],"award-info":[{"award-number":["5G12MD007592"]}],"id":[{"id":"10.13039\/100006545","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Hydrogen sulfide has emerged as a critical endogenous signaling transmitter and a potentially versatile therapeutic agent. The key challenges in this field include the lack of approved hydrogen sulfide-releasing probes for in human exploration and the lack of controllable hydrogen sulfide promoieties that can be flexibly installed for therapeutics development. Here we report the identification of the widely used antithrombotic drug clopidogrel as a clinical hydrogen sulfide donor. Clopidogrel is metabolized in patients to form a circulating metabolite that contains a thioenol substructure, which is found to undergo spontaneous degradation to release hydrogen sulfide. Model studies demonstrate that thioenol derivatives are a class of controllable promoieties that can be conveniently installed on a minimal structure of ketone with an \u03b1-hydrogen. These results can provide chemical tools for advancing hydrogen sulfide biomedical research as well as developing hydrogen sulfide-releasing drugs.<\/jats:p>","DOI":"10.1038\/s41467-018-06373-0","type":"journal-article","created":{"date-parts":[[2018,9,21]],"date-time":"2018-09-21T08:03:44Z","timestamp":1537517024000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Clopidogrel as a donor probe and thioenol derivatives as flexible promoieties for enabling H2S biomedicine"],"prefix":"10.1038","volume":"9","author":[{"given":"Yaoqiu","family":"Zhu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elkin L.","family":"Romero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaodong","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angel J.","family":"Sanca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Congkuo","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cai","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zubair A.","family":"Karim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatima Z.","family":"Alshbool","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fadi T.","family":"Khasawneh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2982-2601","authenticated-orcid":false,"given":"Jiang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dafang","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Geng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,9,27]]},"reference":[{"key":"6373_CR1","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1096\/fj.02-0211hyp","volume":"16","author":"R Wang","year":"2002","unstructured":"Wang, R. Two\u2019s company, three\u2019s a crowd: can H2S be the third endogenous gaseous transmitter? FASEB J. 16, 1792\u20131798 (2002).","journal-title":"FASEB J."},{"key":"6373_CR2","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1111\/j.1471-4159.2010.06580.x","volume":"113","author":"MM Gadalla","year":"2010","unstructured":"Gadalla, M. M. & Snyder, S. H. Hydrogen sulfide as a gasotransmitter. J. Neurochem. 113, 14\u201326 (2010).","journal-title":"J. Neurochem."},{"key":"6373_CR3","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.pharep.2015.01.005","volume":"67","author":"J Beltowski","year":"2015","unstructured":"Beltowski, J. Hydrogen sulfide in pharmacology and medicine - an update. Pharmacol. Rep. 67, 647\u2013658 (2015).","journal-title":"Pharmacol. Rep."},{"key":"6373_CR4","first-page":"1253","volume":"118","author":"MR Filipovic","year":"2018","unstructured":"Filipovic, M. R., Zivanovic, J., Alvarez, B. & Banerjee, R. Chemical biology of H2S signaling through persulfidation.\u00a0Chem. Rev. 118, 1253\u20131337 (2018).","journal-title":"Chemical biology of H2S signaling through persulfidation"},{"key":"6373_CR5","doi-asserted-by":"publisher","first-page":"6108","DOI":"10.1039\/C6CS00212A","volume":"45","author":"MD Hartle","year":"2016","unstructured":"Hartle, M. D. & Pluth, M. D. A practical guide to working with H2S at the interface of chemistry and biology. Chem. Soc. Rev. 45, 6108\u20136117 (2016).","journal-title":"Chem. Soc. Rev."},{"key":"6373_CR6","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1089\/ars.2011.4005","volume":"17","author":"YH Liu","year":"2012","unstructured":"Liu, Y. H. et al. Hydrogen sulfide in the mammalian cardiovascular system. Antioxid. Redox Signal. 17, 141\u2013185 (2012).","journal-title":"Antioxid. Redox. Signal."},{"key":"6373_CR7","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1038\/nrd2425","volume":"6","author":"C Szabo","year":"2007","unstructured":"Szabo, C. Hydrogen sulphide and its therapeutic potential. Nat. Rev. Drug Discov. 6, 917\u2013935 (2007).","journal-title":"Nat. Rev. Drug. Discov."},{"key":"6373_CR8","doi-asserted-by":"publisher","first-page":"686","DOI":"10.3389\/fphar.2017.00686","volume":"8","author":"L Pan","year":"2017","unstructured":"Pan, L., Qin, M., Liu, X. & Zhu, Y. The role of hydrogen sulfide on cardiovascular homeostasis: an overview with update on immunomodulation. Front. Pharmacol. 8, 686 (2017).","journal-title":"Front. Pharmacol."},{"key":"6373_CR9","doi-asserted-by":"publisher","first-page":"403S","DOI":"10.3945\/jn.114.208066","volume":"146","author":"JM Bradley","year":"2016","unstructured":"Bradley, J. M., Organ, C. L. & Lefer, D. J. Garlic-derived organic polysulfides and myocardial protection. J. Nutr. 146, 403S\u2013409S (2016).","journal-title":"J. Nutr."},{"key":"6373_CR10","doi-asserted-by":"publisher","first-page":"2633","DOI":"10.1055\/s-0035-1560638","volume":"26","author":"M Pluth","year":"2015","unstructured":"Pluth, M. et al. Natural products containing hydrogen sulfide releasing moieties. Synlett 26, 2633\u20132643 (2015).","journal-title":"Synlett."},{"key":"6373_CR11","doi-asserted-by":"publisher","first-page":"17977","DOI":"10.1073\/pnas.0705710104","volume":"104","author":"GA Benavides","year":"2007","unstructured":"Benavides, G. A. et al. Hydrogen sulfide mediates the vasoactivity of garlic. Proc. Natl. Acad. Sci. USA 104, 17977\u201317982 (2007).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"6373_CR12","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1124\/pr.117.014050","volume":"69","author":"C Szabo","year":"2017","unstructured":"Szabo, C. & Papapetropoulos, A. International union of basic and clinical pharmacology. CII: pharmacological modulation of H2S levels: H2S donors and H2S biosynthesis inhibitors. Pharmacol. Rev. 69, 497\u2013564 (2017).","journal-title":"Pharmacol. Rev."},{"key":"6373_CR13","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1089\/ars.2017.7068","volume":"28","author":"JL Wallace","year":"2018","unstructured":"Wallace, J. L. et al. Hydrogen sulfide-releasing therapeutics: translation to the clinic. Antioxid. Redox Signal. 28, 1533\u20131540 (2018).","journal-title":"Antioxid. Redox. Signal."},{"key":"6373_CR14","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.apsb.2015.06.004","volume":"5","author":"Y Zheng","year":"2015","unstructured":"Zheng, Y., Ji, X., Ji, K. & Wang, B. Hydrogen sulfide prodrugs - a review. Acta Pharm. Sin. B 5, 367\u2013377 (2015).","journal-title":"Acta Pharm. Sin. B"},{"key":"6373_CR15","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/nrd4433","volume":"14","author":"JL Wallace","year":"2015","unstructured":"Wallace, J. L. & Wang, R. Hydrogen sulfide-based therapeutics: exploiting a unique but ubiquitous gasotransmitter. Nat. Rev. Drug Discov. 14, 329\u2013345 (2015).","journal-title":"Nat. Rev. Drug. Discov."},{"key":"6373_CR16","doi-asserted-by":"publisher","first-page":"664","DOI":"10.3389\/fphar.2017.00664","volume":"8","author":"CT Yang","year":"2017","unstructured":"Yang, C. T. et al. Recent development of hydrogen sulfide releasing\/stimulating reagents and their potential applications in cancer and glycometabolic disorders. Front. Pharmacol. 8, 664 (2017).","journal-title":"Front. Pharmacol."},{"key":"6373_CR17","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1002\/med.21433","volume":"38","author":"Y Zheng","year":"2018","unstructured":"Zheng, Y. et al. Toward hydrogen sulfide based therapeutics: critical drug delivery and developability issues. Med. Res. Rev. 38, 57\u2013100 (2018).","journal-title":"Med. Res. Rev."},{"key":"6373_CR18","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1021\/ja1085723","volume":"133","author":"Y Zhao","year":"2011","unstructured":"Zhao, Y., Wang, H. & Xian, M. Cysteine-activated hydrogen sulfide (H2S) donors. J. Am. Chem. Soc. 133, 15\u201317 (2011).","journal-title":"J. Am. Chem. Soc."},{"key":"6373_CR19","doi-asserted-by":"publisher","first-page":"7501","DOI":"10.1021\/acs.jmedchem.5b01033","volume":"58","author":"Y Zhao","year":"2015","unstructured":"Zhao, Y. et al. Design, synthesis, and cardioprotective effects of n-mercapto-based hydrogen sulfide donors. J. Med. Chem. 58, 7501\u20137511 (2015).","journal-title":"J. Med. Chem."},{"key":"6373_CR20","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1021\/ol500385a","volume":"16","author":"JC Foster","year":"2014","unstructured":"Foster, J. C., Powell, C. R., Radzinski, S. C. & Matson, J. B. S-aroylthiooximes: a facile route to hydrogen sulfide releasing compounds with structure-dependent release kinetics. Org. Lett. 16, 1558\u20131561 (2014).","journal-title":"Org. Lett."},{"key":"6373_CR21","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1021\/cb400090d","volume":"8","author":"Y Zhao","year":"2013","unstructured":"Zhao, Y. et al. Controllable hydrogen sulfide donors and their activity against myocardial ischemia-reperfusion injury. ACS Chem. Biol. 8, 1283\u20131290 (2013).","journal-title":"ACS. Chem. Biol."},{"key":"6373_CR22","doi-asserted-by":"publisher","first-page":"2268","DOI":"10.1002\/cbic.201300552","volume":"14","author":"T Roger","year":"2013","unstructured":"Roger, T. et al. New biologically active hydrogen sulfide donors. ChemBioChem 14, 2268\u20132271 (2013).","journal-title":"Chembiochem"},{"key":"6373_CR23","doi-asserted-by":"publisher","first-page":"16365","DOI":"10.1021\/jacs.7b09527","volume":"139","author":"Y Zhao","year":"2017","unstructured":"Zhao, Y., Henthorn, H. A. & Pluth, M. D. Kinetic insights into hydrogen sulfide delivery from caged-carbonyl sulfide isomeric donor platforms. J. Am. Chem. Soc. 139, 16365\u201316376 (2017).","journal-title":"J. Am. Chem. Soc."},{"key":"6373_CR24","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1021\/acschembio.7b00279","volume":"12","author":"AK Steiger","year":"2017","unstructured":"Steiger, A. K. et al. Inhibition of mitochondrial bioenergetics by esterase-triggered COS\/H2S donors. ACS Chem. Biol. 12, 2117\u20132123 (2017).","journal-title":"ACS. Chem. Biol."},{"key":"6373_CR25","doi-asserted-by":"publisher","first-page":"2278","DOI":"10.1021\/acs.orglett.7b00808","volume":"19","author":"Y Zhao","year":"2017","unstructured":"Zhao, Y., Bolton, S. G. & Pluth, M. D. Light-activated COS\/H2S donation from photocaged thiocarbamates. Org. Lett. 19, 2278\u20132281 (2017).","journal-title":"Org. Lett."},{"key":"6373_CR26","doi-asserted-by":"publisher","first-page":"14638","DOI":"10.1002\/anie.201608052","volume":"55","author":"Y Zhao","year":"2016","unstructured":"Zhao, Y. & Pluth, M. D. Hydrogen sulfide donors activated by reactive oxygen species. Angew. Chem. Int. Ed. 55, 14638\u201314642 (2016).","journal-title":"Angew. Chem. Int. Ed."},{"key":"6373_CR27","doi-asserted-by":"publisher","first-page":"7256","DOI":"10.1021\/jacs.6b03780","volume":"138","author":"AK Steiger","year":"2016","unstructured":"Steiger, A. K., Pardue, S., Kevil, C. G. & Pluth, M. D. Self-immolative thiocarbamates provide access to triggered H2S donors and analyte replacement fluorescent probes. J. Am. Chem. Soc. 138, 7256\u20137259 (2016).","journal-title":"J. Am. Chem. Soc."},{"key":"6373_CR28","doi-asserted-by":"publisher","first-page":"13477","DOI":"10.1021\/jacs.6b07204","volume":"138","author":"CR Powell","year":"2016","unstructured":"Powell, C. R. et al. Therapeutic delivery of H2S via COS: small molecule and polymeric donors with benign byproducts. J. Am. Chem. Soc. 138, 13477\u201313480 (2016).","journal-title":"J. Am. Chem. Soc."},{"key":"6373_CR29","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1021\/ml400239a","volume":"4","author":"A Martelli","year":"2013","unstructured":"Martelli, A. et al. Arylthioamides as H2S donors: L-cysteine-activated releasing properties and vascular effects in vitro and in vivo. ACS Med. Chem. Lett. 4, 904\u2013908 (2013).","journal-title":"ACS Med. Chem. Lett."},{"key":"6373_CR30","doi-asserted-by":"publisher","first-page":"7512","DOI":"10.1021\/acs.jmedchem.7b00888","volume":"60","author":"E Barresi","year":"2017","unstructured":"Barresi, E. et al. Iminothioethers as hydrogen sulfide donors: from the gasotransmitter release to the vascular effects. J. Med. Chem. 60, 7512\u20137523 (2017).","journal-title":"J. Med. Chem."},{"key":"6373_CR31","doi-asserted-by":"publisher","first-page":"72","DOI":"10.3389\/fchem.2017.00072","volume":"5","author":"S Sestito","year":"2017","unstructured":"Sestito, S. et al. Hydrogen sulfide: a worthwhile tool in the design of new multitarget drugs. Front. Chem. 5, 72 (2017).","journal-title":"Front. Chem."},{"key":"6373_CR32","doi-asserted-by":"publisher","first-page":"2908","DOI":"10.1161\/01.CIR.0000072771.11429.83","volume":"107","author":"PA Gurbel","year":"2003","unstructured":"Gurbel, P. A., Bliden, K. P., Hiatt, B. L. & O\u2019Connor, C. M. Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity. Circulation 107, 2908\u20132913 (2003).","journal-title":"Circulation"},{"key":"6373_CR33","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/nrcardio.2010.71","volume":"7","author":"K Kolandaivelu","year":"2010","unstructured":"Kolandaivelu, K. & Bhatt, D. L. Overcoming \u2018resistance\u2019 to antiplatelet therapy: targeting the issue of nonadherence. Nat. Rev. Cardiol. 7, 461\u2013467 (2010).","journal-title":"Nat. Rev. Cardiol"},{"key":"6373_CR34","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1124\/dmd.30.11.1288","volume":"30","author":"JM Pereillo","year":"2002","unstructured":"Pereillo, J. M. et al. Structure and stereochemistry of the active metabolite of clopidogrel. Drug Metab. Dispos. 30, 1288\u20131295 (2002).","journal-title":"Drug Metab. Dispos."},{"key":"6373_CR35","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1021\/tx8004828","volume":"22","author":"PM Dansette","year":"2009","unstructured":"Dansette, P. M., Libraire, J., Bertho, G. & Mansuy, D. Metabolic oxidative cleavage of thioesters: evidence for the formation of sulfenic acid intermediates in the bioactivation of the antithrombotic prodrugs ticlopidine and clopidogrel. Chem. Res. Toxicol. 22, 369\u2013373 (2009).","journal-title":"Chem. Res. Toxicol."},{"key":"6373_CR36","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1160\/TH10-09-0582","volume":"105","author":"G Tuffal","year":"2011","unstructured":"Tuffal, G. et al. An improved method for specific and quantitative determination of the clopidogrel active metabolite isomers in human plasma. Thromb. Haemost. 105, 696\u2013705 (2011).","journal-title":"Thromb. Haemost."},{"key":"6373_CR37","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.jchromb.2013.02.031","volume":"926","author":"MT Furlong","year":"2013","unstructured":"Furlong, M. T. et al. A validated HPLC-MS\/MS assay for quantifying unstable pharmacologically active metabolites of clopidogrel in human plasma: application to a clinical pharmacokinetic study. J. Chromatogr. B 926, 36\u201341 (2013).","journal-title":"J. Chromatogr. B."},{"key":"6373_CR38","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1038\/nm.2436","volume":"17","author":"PM Dansette","year":"2011","unstructured":"Dansette, P. M., Rosi, J., Bertho, G. & Mansuy, D. Paraoxonase-1 and clopidogrel efficacy. Nat. Med. 17, 1040\u20131041 (2011).","journal-title":"Nat. Med."},{"key":"6373_CR39","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1021\/tx2004085","volume":"25","author":"PM Dansette","year":"2012","unstructured":"Dansette, P. M., Rosi, J., Bertho, G. & Mansuy, D. Cytochromes P450 catalyze both steps of the major pathway of clopidogrel bioactivation, whereas paraoxonase catalyzes the formation of a minor thiol metabolite isomer. Chem. Res. Toxicol. 25, 348\u2013356 (2012).","journal-title":"Chem. Res. Toxicol."},{"key":"6373_CR40","doi-asserted-by":"publisher","first-page":"2856","DOI":"10.1093\/eurheartj\/ehs042","volume":"33","author":"I Gong","year":"2012","unstructured":"Gong, I. Y. et al. Clarifying the importance of CYP2C19 and PON1 in the mechanism of clopidogrel bioactivation and in vivo antiplatelet response. Eur. Heart J. 33, 2856\u20132864 (2012).","journal-title":"Eur. Heart J."},{"key":"6373_CR41","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.jpba.2017.11.019","volume":"149","author":"C Liu","year":"2018","unstructured":"Liu, C. et al. Development and validation of a sensitive and rapid UHPLC-MS\/MS method for the simultaneous quantification of the common active and inactive metabolites of vicagrel and clopidogrel in human plasma. J. Pharm. Biomed. Anal. 149, 394\u2013402 (2018).","journal-title":"J. Pharm. Biomed. Anal."},{"key":"6373_CR42","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1002\/jcph.293","volume":"54","author":"RB Horenstein","year":"2014","unstructured":"Horenstein, R. B. et al. Effectiveness of clopidogrel dose escalation to normalize active metabolite exposure and antiplatelet effects in CYP2C19 poor metabolizers. J. Clin. Pharmacol. 54, 865\u2013873 (2014).","journal-title":"J. Clin. Pharmacol."},{"key":"6373_CR43","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s40262-013-0105-2","volume":"53","author":"M Karazniewicz-\u0141ada","year":"2014","unstructured":"Karazniewicz-\u0141ada, M. et al. Clinical pharmacokinetics of clopidogrel and its metabolites in patients with cardiovascular diseases. Clin. Pharmacokinet. 53, 155\u2013164 (2014).","journal-title":"Clin. Pharmacokinet."},{"key":"6373_CR44","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/nm.2281","volume":"17","author":"HJ Bouman","year":"2011","unstructured":"Bouman, H. J. et al. Paraoxonase-1 is a major determinant of clopidogrel efficacy. Nat. Med. 17, 110\u2013116 (2011).","journal-title":"Nat. Med."},{"key":"6373_CR45","doi-asserted-by":"publisher","first-page":"e5660","DOI":"10.1590\/1414-431x20165660","volume":"50","author":"JFM Marchini","year":"2017","unstructured":"Marchini, J. F. M. et al. Decreased platelet responsiveness to clopidogrel correlates with CYP2C19 and PON1 polymorphisms in atherosclerotic patients. Braz. J. Med. Biol. Res. 50, e5660 (2017).","journal-title":"Braz. J. Med. Biol. Res."},{"key":"6373_CR46","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.thromres.2013.09.008","volume":"132","author":"R Nishio","year":"2013","unstructured":"Nishio, R. et al. Paraoxonase-1 activity affects the clopidogrel response in CYP2C19 loss-of-function carriers. Thromb. Res. 132, 558\u2013564 (2013).","journal-title":"Thromb. Res."},{"key":"6373_CR47","doi-asserted-by":"publisher","first-page":"3893","DOI":"10.1016\/j.tet.2014.04.037","volume":"70","author":"G Bluet","year":"2014","unstructured":"Bluet, G. et al. Synthesis of the stabilized active metabolite of clopidogrel. Tetrahedron 70, 3893\u20133900 (2014).","journal-title":"Tetrahedron"},{"key":"6373_CR48","doi-asserted-by":"publisher","first-page":"3342","DOI":"10.1021\/jm300038c","volume":"55","author":"J Shan","year":"2012","unstructured":"Shan, J. et al. Overcoming clopidogrel resistance: discovery of vicagrel as a highly potent and orally bioavailable antiplatelet agent. J. Med. Chem. 55, 3342\u20133352 (2012).","journal-title":"J. Med. Chem."},{"key":"6373_CR49","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/0003-2697(65)90051-5","volume":"11","author":"LM Siegel","year":"1965","unstructured":"Siegel, L. M. A direct microdetermination for sulfide. Anal. Biochem. 11, 126\u2013132 (1965).","journal-title":"Anal. Biochem."},{"key":"6373_CR50","doi-asserted-by":"publisher","first-page":"9213","DOI":"10.1021\/acs.analchem.6b02459","volume":"88","author":"Z Wu","year":"2016","unstructured":"Wu, Z., Liang, D. & Tang, X. Visualizing hydrogen sulfide in mitochondria and lysosome of living cells and in tumors of living mice with positively charged fluorescent chemosensors. Anal. Chem. 88, 9213\u20139218 (2016).","journal-title":"Anal. Chem."},{"key":"6373_CR51","doi-asserted-by":"publisher","first-page":"8802","DOI":"10.1039\/C7CC05339H","volume":"53","author":"N Velusamy","year":"2017","unstructured":"Velusamy, N. et al. A bioorthogonal fluorescent probe for mitochondrial hydrogen sulfide: new strategy for cancer cell labeling. Chem. Commun. 53, 8802\u20138805 (2017).","journal-title":"Chem. Commun."},{"key":"6373_CR52","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1126\/science.1162667","volume":"322","author":"G Yang","year":"2008","unstructured":"Yang, G. et al. H2S as a physiologic vasorelaxant: hypertension in mice with deletion of cystathionine gamma-lyase. Science 322, 587\u2013590 (2008).","journal-title":"Science"},{"key":"6373_CR53","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1161\/CIRCRESAHA.114.300505","volume":"114","author":"DJ Polhemus","year":"2014","unstructured":"Polhemus, D. J. & Lefer, D. J. Emergence of hydrogen sulfide as an endogenous gaseous signaling molecule in cardiovascular disease. Circ. Res. 114, 730\u2013737 (2014).","journal-title":"Circ. Res."},{"key":"6373_CR54","first-page":"15607","volume":"9","author":"G Li","year":"2016","unstructured":"Li, G. et al. Hydrogen sulfide exerts antithrombotic effects and inhibits deep vein thrombosis through NOS-PECAM-1 signaling pathway. Int. J. Clin. Exp. Med. 9, 15607\u201315620 (2016).","journal-title":"Int. J. Clin. Exp. Med."},{"key":"6373_CR55","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1248\/bpb.b13-00018","volume":"36","author":"H Nishikawa","year":"2013","unstructured":"Nishikawa, H. et al. Inhibition by hydrogen sulfide of rabbit platelet aggregation and calcium mobilization. Biol. Pharm. Bull. 36, 1278\u20131282 (2013).","journal-title":"Biol. Pharm. Bull."},{"key":"6373_CR56","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.hlc.2014.05.019","volume":"24","author":"L Gao","year":"2015","unstructured":"Gao, L. et al. Hydrogen sulfide inhibits human platelet aggregation in vitro in part by interfering gap junction channels: effects of ACS14, a hydrogen sulfide-releasing aspirin. Heart Lung. Circ. 24, 77\u201385 (2015).","journal-title":"Heart. Lung. Circ."},{"key":"6373_CR57","doi-asserted-by":"publisher","first-page":"R1930","DOI":"10.1152\/ajpregu.00025.2008","volume":"294","author":"NL Whitfield","year":"2008","unstructured":"Whitfield, N. L. et al. Reappraisal of H2S\/sulfide concentration in vertebrate blood and its potential significance in ischemic preconditioning and vascular signaling. Am. J. Physiol. Regul. Integr. Comp. Physiol. 294, R1930\u2013R1937 (2008).","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"6373_CR58","doi-asserted-by":"publisher","first-page":"R1479","DOI":"10.1152\/ajpregu.90566.2008","volume":"295","author":"J Furne","year":"2008","unstructured":"Furne, J., Saeed, A. & Levitt, M. D. Whole tissue hydrogen sulfide concentrations are orders of magnitude lower than presently accepted values. Am. J. Physiol. Regul. Integr. Comp. Physiol. 295, R1479\u2013R1485 (2008).","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"6373_CR59","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1146\/annurev-pharmtox-010510-100505","volume":"51","author":"L Li","year":"2011","unstructured":"Li, L., Rose, P. & Moore, P. K. Hydrogen sulfide and cell signaling. Annu. Rev. Pharmacol. Toxicol. 51, 169\u2013187 (2011).","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"6373_CR60","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1093\/cvr\/cvu026","volume":"102","author":"M Bucci","year":"2014","unstructured":"Bucci, M. et al. Hydrogen sulfide accounts for the peripheral vascular effects of zofenopril independently of ACE inhibition. Cardiovasc. Res. 102, 138\u2013147 (2014).","journal-title":"Cardiovasc. Res."},{"key":"6373_CR61","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.bbrc.2015.04.143","volume":"462","author":"FZ Alshbool","year":"2015","unstructured":"Alshbool, F. Z. et al. The regulator of G-protein signaling 18 regulates platelet aggregation, hemostasis and thrombosis. Biochem. Biophys. Res. Commun. 462, 378\u2013382 (2015).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"6373_CR62","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1161\/ATVBAHA.114.304509","volume":"35","author":"ZA Karim","year":"2015","unstructured":"Karim, Z. A. et al. Characterization of a novel function-blocking antibody targeted against the platelet P2Y1 receptor. Arterioscler. Thromb. Vasc. Biol. 35, 637\u2013644 (2015).","journal-title":"Arterioscler. Thromb. Vasc. Biol."}],"updated-by":[{"DOI":"10.1038\/s41467-018-06832-8","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2018,10,10]],"date-time":"2018-10-10T00:00:00Z","timestamp":1539129600000}}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-06373-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-06373-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-06373-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T13:17:01Z","timestamp":1671542221000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-06373-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,27]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["6373"],"URL":"https:\/\/doi.org\/10.1038\/s41467-018-06373-0","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.734096370.793556119","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,27]]},"assertion":[{"value":"23 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2018","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original version of this Article contained an error in the spelling of the author Bin Geng, which was incorrectly given as Bing Geng. This has been corrected in both the PDF and HTML versions of the Article.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3952"}}